GraniteShares has rolled out four new ETFs under its YieldBOOST platform, aiming to tap investor demand for high-frequency income strategies tied to high-conviction market themes.
The ETFs offering exposure to biotech, financials, technology, and long-duration Treasuries through options-based strategies built on 3x leveraged instruments:
- GraniteShares YieldBOOST Biotech ETF (NASDAQ:BIOY),
- GraniteShares YieldBOOST Financials ETF (NASDAQ:FINY),
- GraniteShares YieldBOOST Technology ETF (NASDAQ:TECY), and
- GraniteShares YieldBOOST 20Y+ Treasuries ETF (NASDAQ:FIYY)
The firm designed the funds to generate weekly income by writing put options on leveraged ETFs tracking benchmarks such as the S&P Biotechnology Select Industry Index, Financial Select Sector Index, Technology Select Sector Index, and the ICE U.S. Treasury 20+ Year Bond Index.
GraniteShares CEO Will Rhind said the strategy seeks to harness elevated implied volatility in leveraged products to enhance income potential, though distributions are not guaranteed.
Key Features
- Options-driven weekly income: Each fund primarily sells put options on 3x leveraged ETFs to capture higher premiums from volatility
- Sector-focused exposure: Targets biotech (BIOY), financials (FINY), and technology (TECY), alongside long-duration bonds (FIYY)
- High volatility angle: Strategies aim to benefit from sectors with structurally elevated implied volatility, such as biotech and rate-sensitive Treasuries
- Alternative to traditional income: Designed for investors seeking yield beyond conventional dividend or bond strategies
- Indirect leveraged exposure: While not directly holding leveraged ETFs, income is derived from options tied to those instruments
The launch builds on GraniteShares' push into income-oriented ETFs, leveraging its expertise in high-conviction and leveraged strategies, with $11.58 billion in assets under management as of late April.
Image: Shutterstock